dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Canon's Vital Images wins DoD contract Maximum $100 million fixed‐price contract for radiology and imaging systems

Are you GDPR compliant? It's not just a question for EU-based companies Here are the top eight considerations

Security tightening at hospitals for patient safety A noticeable change is occurring at the front entrance to hospitals

Johnson & Johnson completes Auris Health deal The $3.4 billion acquisition could include additional payments up to $2.35 billion

Follow-up imaging study points to benefits of automated notification Raising the bar on manual callbacks

Change Healthcare files for IPO Could raise as much as $100 million, listing on Nasdaq

Mergers do nothing for quality of care, lower patient satisfaction, says study Based on 29 data points and the assessment of 16 processes of care

GE Healthcare IPO on hold as new deal takes spotlight Selling biopharma business to Danaher for over $21 billion

Johnson & Johnson to acquire Auris Health for $3.4 billion With possible $2.35 billion added if certain milestones are hit

Asheville Radiology Association joins Strategic Radiology The latest expansion by the imaging coalition brings 43 new physicians to the table

Olympus promotes U.S.-Based leaders to global roles

by Thomas Dworetzky , Contributing Reporter
Olympus has elevated several of its U.S.-based leaders to senior-level global roles. The moves, slated to happen April 1, are indications of the company's ongoing globalization efforts.

Nacho Abia will add co-head of the newly created Therapeutic Solutions division to his present responsibilities as president and CEO of Olympus Corporation of the Americas (OCA). In the new position he will be responsible “for the new global business development function across all three core businesses – Medical, Scientific and Imaging,” the company said in a statement.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



“My colleagues and I are delighted to assume our new global roles within Olympus, which continues to adapt to meet the needs of the rapidly changing international markets. In our new positions, we look forward to leveraging the experience and expertise we have developed at Olympus Corporation of the Americas in order to support Olympus' worldwide growth and to execute the Company's increasingly global vision,” said Abia.

His other colleagues, include Tomohisa "Tomo" Sakurai, who has been named the other co-head of the Therapeutic Solutions business, and relocated to OCA's Center Valley, Pennsylvania, headquarters from Tokyo in 2018.

In addition, Richard Lebitz, presently the executive director of internal audit for OCA, will move up to global chief internal audit officer of Olympus.

And Mark Miller has been picked to be company's global chief communications officer. He will also act as regional head of communications for the Americas.

Olympus also announced numerous other transformation efforts in another statement. These include a major reorganization of its medical business into a pair of global divisions – Endoscopic Solutions and Therapeutic Solutions.

The Endoscopic Solutions division will continue to be managed from Japan, but the Therapeutic Solutions division, with its typically faster product life cycles, will be overseen from the U.S., as this is the largest therapeutic device market.

“By managing Therapeutics out of the U.S., we will be extremely well positioned to pursue the right business opportunities and partnerships,” Abia noted, adding, “We are excited to help lead the continued transformation of Olympus into a world-class global medical technology company.”

In addition, Olympus also announced that it would propose giving a board seat to activist shareholder U.S. hedge fund ValueAct Capital, which now holds 5.04 percent of the company's outstanding shares, according to Reuters, which noted that the move comes despite the fact that such investors are widely viewed in Japan as “asset-strippers to be resisted.”
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED